NANOG and fragile X syndrome: Expression of the stem cell markers NANOG, TRA-160, and SSEA were not detected by immunocytochemistry in either control or FXS-affected neural precursors (Supplementary Figure S3), indicating that control and FXS-affected neural precursors did not transit through a pluripotency stage prior to differentiation.